TransMedics Reports Second Quarter 2019 Financial Results
TransMedics Group, Inc. (TMDX)
Last transmedics group, inc. earnings: 3/2 04:05 pm
Check Earnings Report
Company Research
Source: GlobeNewswire
ANDOVER, Mass., Aug. 07, 2019 (GLOBE NEWSWIRE) -- TransMedics Group, Inc. (“TransMedics”) (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure, today reported financial results for the quarter ended June 29, 2019. Recent Highlights Recorded net revenue of $5.7 million in the second quarter of 2019, representing 94% growth compared to the second quarter of 2018Commenced OCS Lung commercial activities for expanded indications in the U.S.Lancet Respiratory Medicine peer-reviewed publication of OCS Lung EXPAND clinical trial results reporting the use of the OCS Lung System resulted in 87% successful utilization of donor lungs that were initially deemed not transplantable based on cold storage limitationsOrgan Care System (OCS™) Lung utilized for two successful extended duration lung transplantations using donor organs from Hawaii “We are pleased by our results from the second quarter, as w
Show less
Read more
Impact Snapshot
Event Time:
TMDX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TMDX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TMDX alerts
High impacting TransMedics Group, Inc. news events
Weekly update
A roundup of the hottest topics
TMDX
News
- TransMedics to Participate in the 43rd Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]Yahoo! Finance
- TransMedics to Participate in the 43rd Annual J.P. Morgan Healthcare ConferencePR Newswire
- TransMedics Group, Inc. (NASDAQ: TMDX) had its "neutral" rating re-affirmed by analysts at JPMorgan Chase & Co.. They now have a $75.00 price target on the stock, down previously from $116.00.MarketBeat
- TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)PR Newswire
- TransMedics Group, Inc. (NASDAQ: TMDX) had its "hold" rating re-affirmed by analysts at Needham & Company LLC.MarketBeat
TMDX
Earnings
- 10/28/24 - Miss
TMDX
Sec Filings
- 12/11/24 - Form 4
- 12/9/24 - Form 8-K
- 12/6/24 - Form SCHEDULE
- TMDX's page on the SEC website